Brevan Howard Capital Management LP Bristol Myers Squibb CO Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 36,656 shares of BMY stock, worth $2.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,656
Previous 6,527
461.61%
Holding current value
$2.12 Million
Previous $271,000
599.63%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.16 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.37 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...